In MM, but not MGUS, myeloma cells shed soluble MHC class I-related chain A (sMICA), resulting in downregulation of NKG2D expression, impaired lymphocytotoxicity, and resistance to NKG2D-mediated killing (81–83). Here, KLRK1 is linked to plasma cell myeloma.